Update on Barriers to Pharmacotherapy for Opioid Use Disorders

被引:0
作者
Anjalee Sharma
Sharon M. Kelly
Shannon Gwin Mitchell
Jan Gryczynski
Kevin E. O’Grady
Robert P. Schwartz
机构
[1] Friends Research Institute,Department of Psychology
[2] Inc,undefined
[3] University of Maryland,undefined
[4] College Park,undefined
来源
Current Psychiatry Reports | 2017年 / 19卷
关键词
Methadone; Buprenorphine; Naltrexone; Pharmacotherapy for opioid use disorder; Barriers to drug abuse treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Receipt of pharmacotherapy for opioid use disorder by justice-involved US Veterans Health Administration patients
    Finlay, Andrea K.
    Harris, Alex H. S.
    Rosenthal, Joel
    Blue-Howells, Jessica
    Clark, Sean
    McGuire, Jim
    Timko, Christine
    Frayne, Susan M.
    Smelson, David
    Oliva, Elizabeth
    Binswanger, Ingrid
    DRUG AND ALCOHOL DEPENDENCE, 2016, 160 : 222 - 226
  • [22] Pain Management for Patients With Opioid Use Disorders
    Lyden, Abbie
    Neu, Rachel
    ORTHOPAEDIC NURSING, 2025, 44 (01) : 42 - 51
  • [23] Opioid Use Disorder: Treatments and Barriers
    Patel, Karan
    Bunachita, Sean
    Agarwal, Ank A.
    Lyon, Aaron
    Patel, Urvish K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [24] Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)
    Shulman, Matisyahu
    Meyers-Ohki, Sarah
    Novo, Patricia
    Provost, Scott
    Ohrtman, Kaitlyn
    Van Veldhuisen, Paul
    Oden, Neal
    Otterstatter, Michael
    Bailey, Genie L.
    Liu, David
    Rotrosen, John
    Weiss, Roger D.
    V. Nunes, Edward
    CONTEMPORARY CLINICAL TRIALS, 2025, 150
  • [25] Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use
    Jacobson, Nora
    Horst, Julie
    Wilcox-Warren, Liam
    Toy, Alex
    Knudsen, Hannah K.
    Brown, Randy
    Haram, Eric
    Madden, Lynn
    Molfenter, Todd
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2020, 47 (04) : 439 - 448
  • [26] Pharmacotherapy of Substance Use Disorders Challenges and Opportunities
    Meyer, Roger E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (04) : 330 - 333
  • [27] Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
    Fatema Z. Ahmed
    Barbara Andraka-Christou
    M.H. Clark
    Rachel Totaram
    Danielle N. Atkins
    Brandon del Pozo
    Health & Justice, 10
  • [28] Barriers to medications for opioid use disorder in the court system: provider availability, provider "trustworthiness," and cost
    Ahmed, Fatema Z.
    Andraka-Christou, Barbara
    Clark, M. H.
    Totaram, Rachel
    Atkins, Danielle N.
    del Pozo, Brandon
    HEALTH & JUSTICE, 2022, 10 (01)
  • [29] Opioid Use Disorders: Perioperative Management of a Special Population
    Ward, Emine Nalan
    Quaye, Aurora Naa-Afoley
    Wilens, Timothy E.
    ANESTHESIA AND ANALGESIA, 2018, 127 (02) : 539 - 547
  • [30] Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder
    Crotty, Karen
    Freedman, Kenneth I.
    Kampman, Kyle M.
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (02) : 99 - 112